Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainADH_zinc_N

ADH7 FASN

1.79e-0319622PF00107
DomainADH_C

ADH7 FASN

1.79e-0319622IPR013149
Domainzf-MYND

SMYD1 USP19

2.19e-0321622PF01753
DomainZnf_MYND

SMYD1 USP19

2.40e-0322622IPR002893
DomainZF_MYND_1

SMYD1 USP19

2.40e-0322622PS01360
DomainZF_MYND_2

SMYD1 USP19

2.40e-0322622PS50865
DomainGroES-like

ADH7 FASN

2.85e-0324622IPR011032
Domainig

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

3.65e-03190624PF00047
DomainImmunoglobulin

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

3.65e-03190624IPR013151
Pubmed

Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

3.41e-10763411169255
Pubmed

KIR haplotype content at the allele level in 77 Northern Irish families.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

6.80e-10863417200871
Pubmed

NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

6.80e-10863418681957
Pubmed

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.22e-0996347749980
Pubmed

Alternatively spliced forms of human killer inhibitory receptors.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.22e-0996348662091
Pubmed

Natural killer cells and immune surveillance.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

3.19e-091163418830515
Pubmed

[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

3.19e-091163419664392
Pubmed

Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

4.79e-091263420371502
Pubmed

Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

4.79e-091263419181658
Pubmed

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

4.79e-091263419936734
Pubmed

Killer immunoglobulin receptor genes and their HLA-C ligand are associated with Type 1 diabetes in an Eastern Indian population.

KIR2DL2 KIR2DL3 KIR2DS4

5.66e-09363326031759
Pubmed

Evaluation of the genetic diversity of KIR genes in patients with endometrial cancer.

KIR2DS2 KIR2DL2 KIR2DS4

5.66e-09363338387251
Pubmed

Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.

KIR2DS2 KIR2DL2 KIR2DL3

5.66e-09363330696053
Pubmed

Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population.

KIR2DL2 KIR2DL3 KIR2DS4

5.66e-09363332422377
Pubmed

Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis.

KIR2DS2 KIR2DL2 KIR2DL3

5.66e-09363322960345
Pubmed

Imputation of KIR Types from SNP Variation Data.

KIR2DS2 KIR2DL2 KIR2DL3

5.66e-09363326430804
Pubmed

Cutting edge: selective expression of inhibitory or activating killer cell Ig-like receptors in circulating CD4+ T lymphocytes.

KIR2DS2 KIR2DL2 KIR2DL3

5.66e-09363318292496
Pubmed

[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

6.90e-091363418687225
Pubmed

KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

6.90e-091363419934297
Pubmed

Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

6.90e-091363419120281
Pubmed

Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

9.65e-091463419875891
Pubmed

Multiple sclerosis associates with LILRA3 deletion in Spanish patients.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

9.65e-091463419421224
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

9.65e-091463415896204
Pubmed

[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

9.65e-091463419489269
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.31e-081563420082646
Pubmed

Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.31e-081563419926642
Pubmed

Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.31e-081563419850842
Pubmed

Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.31e-081563420207982
Pubmed

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.31e-081563419493232
Pubmed

[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.31e-081563420356536
Pubmed

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.31e-081563420643584
Pubmed

KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.31e-081563417498266
Pubmed

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.31e-081563419326408
Pubmed

Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.75e-081663419897003
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.75e-081663419000141
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.75e-081663420670355
Pubmed

Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.75e-081663419527230
Pubmed

Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.75e-081663420652381
Pubmed

Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.75e-081663418668235
Pubmed

Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.75e-081663419279038
Pubmed

No association of KIR genes with Behcet's disease.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.75e-081663417868255
Pubmed

A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.75e-081663418643961
Pubmed

Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.75e-081663419309280
Pubmed

Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.75e-081663420331834
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.75e-081663416403292
Pubmed

HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

1.75e-081663420210919
Pubmed

Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.

KIR2DS2 KIR2DL2 KIR2DL3

2.26e-08463316929347
Pubmed

KIR/HLA ligand incompatibility in kidney transplantation.

KIR2DS2 KIR2DL2 KIR2DL3

2.26e-08463318091530
Pubmed

Protective KIR-HLA interactions for HCV infection in intravenous drug users.

KIR2DL2 KIR2DL3 KIR2DS4

2.26e-08463319552960
Pubmed

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.29e-081763420173784
Pubmed

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.29e-081763420173792
Pubmed

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.29e-081763420483367
Pubmed

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.29e-081763419968064
Pubmed

[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.29e-081763419218127
Pubmed

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.29e-081763419169284
Pubmed

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.29e-081763420878400
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.29e-081763420650299
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.29e-081763419450876
Pubmed

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.29e-081763419761533
Pubmed

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.93e-081863419630074
Pubmed

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.93e-081863420519398
Pubmed

Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.93e-081863420200544
Pubmed

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.93e-081863419046302
Pubmed

Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.93e-081863419846535
Pubmed

Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.93e-081863420580654
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.93e-081863420210918
Pubmed

KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

3.71e-081963418571006
Pubmed

Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

3.71e-081963418778326
Pubmed

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

3.71e-081963420600442
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

3.71e-081963418848853
Pubmed

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

4.63e-082063420193031
Pubmed

Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.

KIR2DS2 KIR2DL2 KIR2DL3

5.65e-08563316112031
Pubmed

Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.

KIR2DS2 KIR2DL2 KIR2DL3

5.65e-08563318755860
Pubmed

Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.

KIR2DS2 KIR2DL3 KIR2DS4

5.65e-08563310424431
Pubmed

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

5.72e-082163419861144
Pubmed

Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

6.98e-082263420492596
Pubmed

Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.

KIR2DS2 KIR2DL2 KIR2DL3

1.13e-07663317882223
Pubmed

Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.

KIR2DS2 KIR2DL2 KIR2DS4

1.97e-07763314607943
Pubmed

Immunogenetic characteristics of patients with autoimmune gastritis.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

2.24e-072963420082482
Pubmed

A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.

KIR2DL2 KIR2DL3 KIR2DS4

3.15e-07863315730517
Pubmed

Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

4.91e-073563419683555
Pubmed

Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.

KIR2DS2 KIR2DL2 KIR2DL3

6.74e-071063312559621
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].

KIR2DS2 KIR2DL3 KIR2DS4

1.23e-061263317490516
Pubmed

[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].

KIR2DS2 KIR2DL3 KIR2DS4

1.23e-061263320137308
Pubmed

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

KIR2DS2 KIR2DL2 KIR2DS4

2.03e-061463318945962
Pubmed

Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals.

KIR2DL2 KIR2DL3

3.23e-06263225359276
Pubmed

Allelic polymorphism of KIR2DL2/2DL3 in a southern Chinese population.

KIR2DL2 KIR2DL3

3.23e-06263226423800
Pubmed

KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population.

KIR2DS2 KIR2DL2

3.23e-06263222836042
Pubmed

Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C.

KIR2DL2 KIR2DL3

3.23e-06263233846289
Pubmed

Expression of KIR2DL3 and KIR2DS2 natural killer receptors in exercise.

KIR2DS2 KIR2DL3

3.23e-06263221165439
Pubmed

Identification of four novel KIR2DL2 alleles and two novel KIR2DL3 alleles in an East African population.

KIR2DL2 KIR2DL3

3.23e-06263220875478
Pubmed

KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections.

KIR2DS2 KIR2DL2

3.23e-06263230689576
Pubmed

Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patients.

KIR2DS2 KIR2DL2

3.23e-06263232961633
Pubmed

Expression of activating KIR2DS2 and KIR2DS4 genes after hematopoietic cell transplantation: relevance to cytomegalovirus infection.

KIR2DS2 KIR2DS4

3.23e-06263221596150
Pubmed

Interaction of KIR genes and G1M immunoglobulin allotypes confer susceptibility to type 2 diabetes in Puerto Rican Americans.

KIR2DL3 KIR2DS4

3.23e-06263217145370
Pubmed

Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation.

KIR2DS2 KIR2DL3

3.23e-06263218158964
Pubmed

The KIR2DS2/DL2 genotype is associated with adult persistent/chronic and relapsed immune thrombocytopenia independently of FCGR3a-158 polymorphisms.

KIR2DS2 KIR2DL2

3.23e-06263222024796
Pubmed

Killer cell immunoglobulin-like receptor polymorphisms in HLA-identical kidney transplant recipients: lack of 2DL2 and 2DS2 may be associated with poor graft function.

KIR2DS2 KIR2DL2

3.23e-06263217445184
Pubmed

KIR2DL2 and KIR2DS2 as genetic markers to the methotrexate response in rheumatoid arthritis patients.

KIR2DS2 KIR2DL2

3.23e-06263227251940
Pubmed

Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.

KIR2DL2 KIR2DL3

3.23e-06263215248031
InteractionDIO1 interactions

FASN DIO1

8.72e-062602int:DIO1
Cytoband19q13.4

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

4.48e-067963419q13.4
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4

9.99e-0818454620
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZHX3 ZFHX2

6.23e-0415452529
GeneFamilyZinc fingers MYND-type

SMYD1 USP19

1.23e-032145287
ToppCell10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

TCF4 CENPF WT1 CHD9 FHIT MN1

2.49e-071886269858940c616e43441644c5a3bea8d832ee4daf79
ToppCellControl-Epithelial_alveolar-AT_2-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FASN ZNF846 ZFHX2 TSKS

2.16e-05117624c6fc72608d56a389bcd87b5dc98a11e39b79bcb2
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

BRCA2 KIF1A CENPF DNA2

8.64e-0516762450c29ea660bf07b890e4ac1a1985d0761d863dee
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TCF4 BRCA2 CENPF SMYD1

8.64e-05167624bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCellControl-NK|Control / Disease group and Cell class

TCF4 SYNJ2 ELAC1 VAV2

8.84e-05168624683d389c8a1e791bfc773e63148115a21a6566db
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

BRCA2 KIF1A CENPF DNA2

8.84e-05168624d35944fd9fea9934ce1e76b2b35d48e2300cca61
ToppCelldroplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAAF10 DLX5 PPEF2 FHIT

8.84e-05168624ca65321259711321c175ede67bd67a47aad81d7a
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Interneuron|GW23 / Sample Type, Dataset, Time_group, and Cell type.

TCF4 DLX5 MFSD4B

9.33e-0563623c10d344bf32a091deb79e1f128f7dd5e9f4abaa3
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TCF4 SYTL5 DLX5 VAV2

9.46e-051716245efd15300f865ebf651e0888265cbd717bc3b9d3
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TCF4 SYTL5 DLX5 VAV2

9.68e-051726247e1a7700a4c2b1d100da1d6e475e73498ebb605a
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SYTL5 KIAA1217 DLX5 PLCH1

1.06e-04176624322259a35f5c97d73ce7f75835dcdb5c954c91f8
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ADH7 BRCA2 CENPF DNA2

1.13e-0417962488d44b04eb5c079531db663ed98ddb20b60feb9a
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IGFN1 ABCA13 DGKB PLCH1

1.25e-04184624ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IGFN1 ABCA13 DGKB PLCH1

1.25e-041846242cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IGFN1 ABCA13 DGKB PLCH1

1.25e-041846242b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

BRCA2 CENPF SYNJ2 DNA2

1.25e-041846246b2449ac65a2322aa0479fba0d89828f243aabbe
ToppCell343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

BRCA2 CENPF SYNJ2 DNA2

1.25e-04184624e90622b82fa7f16a1faaf7a4724c958f2d83341d
ToppCellfacs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAD51AP2 MIA3 KIF1A ZFHX2

1.36e-04188624a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCellhuman_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

MYO6 KIAA1217 PLCH1 IL17RD

1.36e-04188624b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCellCOVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations)

FASN MYO6 KIAA1217 PLCH1

1.36e-04188624c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCellNS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

BRCA2 CENPF KIR2DL3 DNA2

1.39e-04189624d6bd46abb072b13a6b72f1ca25d19f218cceb1ff
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SYTL5 KIAA1217 PLCH1 VAV2

1.42e-04190624305fbef734c350cfbf786ca7ff6e07093aab56ea
ToppCell10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

TCF4 CHD9 FHIT PCBP2

1.42e-04190624f623f0bdece6002b68ac2207e99408b24a2b1194
ToppCellPBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

BRCA2 SYNJ2 SLC35F6 DNA2

1.42e-041906243f0c7d130f66faea778fe567604edf1b4cdf85b3
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADH7 CENPF ABCA13 STOX1

1.45e-04191624683e5c7e6173644f01e67c98ab7b75d7cb9cce99
ToppCell10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

TCF4 CHD9 FHIT PCBP2

1.45e-04191624054fa0493b00149313c243d39cf39a264044f074
ToppCellNeuron-Postmitotic-Inhibitory_Neuron|World / Primary Cells by Cluster

TCF4 SYTL5 CHD9 DLX5

1.45e-041916244dd9c8117c4499ed9bde127baf2598603a82080d
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SYTL5 KIAA1217 PLCH1 VAV2

1.45e-04191624782bc7946417549ffd39e5b596db659436fa01ba
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TCF4 SYTL5 DLX5 VAV2

1.48e-04192624bf1943715085c4124b1675888b0615c9500ec888
ToppCellNeuron-Postmitotic-Inhibitory_Neuron-SST-MGE1|World / Primary Cells by Cluster

TCF4 SYTL5 CHD9 DLX5

1.48e-04192624bcc499f4c7ba2898ecd9c47bf68c92ed359b81ba
ToppCellPBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

BRCA2 SYNJ2 SLC35F6 DNA2

1.48e-04192624c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SYTL5 KIAA1217 PLCH1 VAV2

1.51e-0419362453bcd50892c379b2a571751f6eb1062436339fe7
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SYTL5 KIAA1217 PLCH1 VAV2

1.51e-04193624c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

TCF4 CHD9 MFSD4B VAV2

1.51e-0419362408696a99309f5b088692ddac8cca35413b5e810d
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SYTL5 KIAA1217 PLCH1 VAV2

1.51e-041936244979862c0c16e6b4baa4c79894f1d237c861f5a5
ToppCellNeuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster

TCF4 SYTL5 CHD9 DLX5

1.51e-041936242eb6e4cff4fe3ce564c1581f6f7df4834895aaa9
ToppCell10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

TCF4 CHD9 FHIT PCBP2

1.54e-04194624f64da5f62e29253d60b9546edf734ba5c17daae1
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SYTL5 KIAA1217 PLCH1 VAV2

1.54e-0419462483863da11dfbe59b2d0a2c08db40b537c150588c
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TCF4 SYTL5 DLX5 VAV2

1.54e-041946244f758718a1233c25c25d99fc1b7b06f906b8b0a2
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TCF4 SYTL5 DLX5 VAV2

1.54e-0419462402a9cc821c2b14aa7d0e55661a5fab66364474e1
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

BRCA2 CENPF SYTL5 DNA2

1.54e-04194624590a9d4f054e6a3685daf752c9354650fcc7d18a
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAD51AP2 MIA3 KIF1A MYO6

1.57e-041956243e519cffa6144a62b06124642a14c9ff39b76554
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAD51AP2 MIA3 KIF1A MYO6

1.57e-041956247796ea9247f4c63762f0de8490fed08b9717fa23
ToppCellBAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ADH7 MYO6 ABCA13 KIAA1217

1.60e-041966241efacc37bbfbd05b5d4db3dd10f6d9a238d23e31
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TCF4 SYTL5 DLX5 VAV2

1.60e-041966247af6c5147ac859353504d19727dbe24f63a29dd4
ToppCelldroplet-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

THAP4 MYO6 ABCA13 DIO1

1.60e-04196624b880c9665d42c76ea1971d4e49d7ecf72fcfafb6
ToppCellBAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ADH7 MYO6 ABCA13 KIAA1217

1.60e-041966243e99a367b7d817e1f1221450fcec20ad7a7c7a2a
ToppCellSevere_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）

ADH7 MYO6 ABCA13 KIAA1217

1.63e-041976245ad3cd4c77016e862041baac3076f8cc0f75c417
ToppCell10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TCF4 KLHL25 DGKB DLX5

1.63e-04197624d9a5b6171867de21d4ef12aa5a802fb4de9e0c00
ToppCellBAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ADH7 MYO6 ABCA13 KIAA1217

1.63e-0419762408b371309cd790b171ed76cabc7d910e71cd2835
ToppCellBronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ADH7 TCF4 ABCA13 KIAA1217

1.63e-041976241e915957ea6a4550ecb9d6ee4b232aa5800faf20
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CENPF ZFHX2 STOX1 PLCH1

1.63e-041976246e4a411ef823ce9e16f420e185e21fa19d13af34
ToppCellBAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

ADH7 MYO6 ABCA13 KIAA1217

1.63e-041976249f49feee38647bbf964974aac96fa75602186b5c
ToppCell10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

TCF4 CENPF CHD9 FHIT

1.66e-041986248aa4149d2c1cec73cfd654db093252ec8ec5ef68
ToppCellBronchus_Control_(B.)-Endothelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

RAD51AP2 KIF1A ZC3H12B TSKS

1.66e-04198624feac39036b5c0ab97b524cc366286942d136d42f
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster

TCF4 CHD9 DLX5 MN1

1.66e-04198624de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCellNS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ADH7 MYO6 ABCA13 KIAA1217

1.66e-04198624a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d
ToppCellBronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MYO6 KIAA1217 PLCH1 FHIT

1.69e-041996245f7da3eab58ace6cddb3179a415cd839d5767958
ToppCellParenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MYO6 KIAA1217 PLCH1 FHIT

1.69e-041996245cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCellNS-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ADH7 MYO6 ABCA13 KIAA1217

1.69e-04199624d64adb68502be596ce55fb2cb63fe1cfa2c5f8ba
ToppCellNeuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic

SYTL5 KIAA1217 PLCH1 VAV2

1.73e-04200624a9cdddc4e985dae59521e557479c24fcc2ac727d
ToppCellNeuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic

SYTL5 KIAA1217 PLCH1 VAV2

1.73e-04200624e79d93d55b25804f2608185168da472301b6ebca
ToppCellcontrol-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ADH7 MYO6 ABCA13 KIAA1217

1.73e-04200624f95bbb94e51ac28b1995026c599ec3a34e012916
ToppCellNeuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic

SYTL5 KIAA1217 PLCH1 VAV2

1.73e-04200624347a510755374c6a66acee326565dfc447993f18
ToppCellNeuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic

SYTL5 KIAA1217 PLCH1 VAV2

1.73e-04200624f3c710f0fc8a7bfb5371d1aff6e3d8f266953153
ToppCellNeuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic

SYTL5 KIAA1217 PLCH1 VAV2

1.73e-042006241639982d9d994918f7912d12d9d7cfcbc9da4145
ToppCellNeuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic

SYTL5 KIAA1217 PLCH1 VAV2

1.73e-042006241276bfa911fddada4235e12e3081baa53164574b
ToppCellcontrol|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ADH7 MYO6 ABCA13 KIAA1217

1.73e-0420062497f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCellNS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ADH7 MYO6 ABCA13 KIAA1217

1.73e-0420062464462a18afca3c1a8548a857924b8166058bf958
ToppCellNeuronal-Inhibitory|Neuronal / cells hierarchy compared to all cells using T-Statistic

TCF4 SYTL5 DLX5 VAV2

1.73e-042006249ff8647e2de0b538e15929dca88ebb20ff7ab043
ToppCellNS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ADH7 MYO6 ABCA13 KIAA1217

1.73e-04200624d014959891893b6d3854a471fba1dc50c6625a0a
ToppCellNeuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic

SYTL5 KIAA1217 PLCH1 VAV2

1.73e-0420062433b9199e0dfc267e2cea20b82d1c167f8adcc635
ToppCellNeuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic

SYTL5 KIAA1217 PLCH1 VAV2

1.73e-042006249719fabddc34051949468a7520289e3c750de4f8
ToppCellNeuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic

SYTL5 KIAA1217 PLCH1 VAV2

1.73e-042006245ec469267747dce3601c1d8ad01af89fa5b29acc
ToppCellNeuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic

SYTL5 KIAA1217 PLCH1 VAV2

1.73e-0420062470a06fd7fb8de2c8ec3e3182e4476ced049daeae
ToppCellNS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ADH7 MYO6 ABCA13 KIAA1217

1.73e-04200624ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCellNeuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic

SYTL5 KIAA1217 PLCH1 VAV2

1.73e-0420062445ddc5ef2caa87ada88327b63ba9b150a6bb3aa5
ToppCellNeuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic

SYTL5 KIAA1217 PLCH1 VAV2

1.73e-04200624320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c
ToppCellLPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KIAA1217 WT1 PLCH1

2.78e-0491623b0658e020f80e56fab9d2aa07e321d9b33d7af2c
ComputationalNeighborhood of ATRX

UBE4B SYNJ2 TTLL5 NFRKB CHD9 DNA2

8.27e-05215376MORF_ATRX
ComputationalNeighborhood of RFC5

UBE4B SYNJ2 NFRKB CHD9

1.41e-0478374MORF_RFC5
ComputationalGenes in the cancer module 332.

CUL4A PCBP2 WDR47

4.82e-0445373MODULE_332
ComputationalGenes in the cancer module 514.

ADH7 FASN

5.10e-0410372MODULE_514
Diseaseunipolar depression, schizophrenia

ZCCHC14 TCF4 FHIT

1.78e-0525603EFO_0003761, MONDO_0005090
DiseaseWILMS TUMOR 1

BRCA2 WT1

6.07e-056602194070
DiseaseWilms tumor 1

BRCA2 WT1

6.07e-056602cv:CN033288
DiseaseNephroblastoma

BRCA2 WT1

1.13e-048602cv:C0027708
DiseaseHereditary Wilms tumor

BRCA2 WT1

1.13e-048602cv:C0677779
DiseaseKidney Wilms tumor

BRCA2 WT1

1.13e-048602cv:CN305775
DiseaseFVC change measurement, response to placebo

KIF1A DGKB

3.13e-0413602EFO_0008344, EFO_0010339
Diseasenephroblastoma (is_implicated_in)

BRCA2 WT1

3.64e-0414602DOID:2154 (is_implicated_in)
DiseaseCorneal astigmatism

DACT2 SLC35F6 VAV2

5.25e-0477603EFO_1002040
DiseaseMammary Carcinoma, Human

FASN BRCA2 CENPF SYNJ2 WT1 APOBEC3A

6.84e-04525606C4704874
DiseaseMammary Neoplasms, Human

FASN BRCA2 CENPF SYNJ2 WT1 APOBEC3A

6.84e-04525606C1257931
DiseaseMammary Neoplasms

FASN BRCA2 CENPF SYNJ2 WT1 APOBEC3A

6.98e-04527606C1458155
DiseaseBreast Carcinoma

FASN BRCA2 CENPF SYNJ2 WT1 APOBEC3A

7.77e-04538606C0678222
DiseaseSeckel syndrome

CENPF DNA2

9.15e-0422602C0265202
Diseasefree androgen index

ADH7 ZHX3 UBE4B DGKB FHIT

9.82e-04374605EFO_0007005
Diseasespontaneous preterm birth

KIAA1217 KTN1-AS1 FHIT

1.16e-03101603EFO_0006917
DiseaseDepressive Symptoms

FASN SYNJ2

1.28e-0326602C0086132
Diseasehypertension, COVID-19

ULK3 EXD1

1.38e-0327602EFO_0000537, MONDO_0100096
Diseaseretinitis pigmentosa (implicated_via_orthology)

DACT2 EPG5

1.38e-0327602DOID:10584 (implicated_via_orthology)
DiseaseMalignant neoplasm of breast

ZCCHC14 FASN BRCA2 CENPF SYNJ2 WT1 APOBEC3A EPG5

1.43e-031074608C0006142
Diseasecoronary artery disease, factor VII measurement

ADH7 MIA3 PMPCB

1.52e-03111603EFO_0001645, EFO_0004619
Diseaselipoprotein A measurement

ADH7 SYNJ2 PMPCB

1.56e-03112603EFO_0006925
DiseaseBilateral Wilms Tumor

BRCA2 WT1

1.59e-0329602C2930471
Diseasecortical thickness

ZHX3 TCF4 EXD1 SLC35F6 DLX5 STOX1 PLCH1 FHIT

1.80e-031113608EFO_0004840

Protein segments in the cluster

PeptideGeneStartEntry
GKPVHHFMNTSTFTE

ADH7

146

P40394
KVLHNPSGVFHFMQS

EPG5

501

Q9HCE0
HLMDPHIFTSNFNNG

APOBEC3A

11

P31941
KFDMNVFTSLHHGFT

ABCA13

1166

Q86UQ4
DFQAPFQTSAAMHHP

DLX5

16

P56178
FHDTIAGPNMGKSHQ

RAD51AP2

1031

Q09MP3
HHDGVSKANFSIGPM

KIR2DS2

76

P43631
NNGTAHFLEHMAFKG

PMPCB

96

O75439
AMEKSHTPFSQGGHF

FAM166C

56

A6NJV1
HHDGVSKANFSIGPM

KIR2DL2

76

P43627
HHDGVSKANFSIGPM

KIR2DS4

76

P43632
GSDMQVSFDHAPHNF

IL17RD

211

Q8NFM7
QPHKAFTFRMHGFES

NFRKB

531

Q6P4R8
HHDGVSKANFSIGPM

KIR2DL3

76

P43628
FPSSFFMQDGHHSSD

TCF4

211

P15884
QKEHFMTPKHEFQAS

EXD1

426

Q8NHP7
FHVFDMRTQHPTKGF

DNAAF10

236

Q96MX6
SFSHHGPNATMTQKT

PRSS54

286

Q6PEW0
DKGAPHMQALHFSFA

MFSD4B

116

Q5TF39
MQQSHFPMTHGNTGF

PCBP2

251

Q15366
HFSEHPSTSKMNAQE

HTATSF1

401

O43719
EKTGMTRNPHFSHDN

DIO1

46

P49895
MGHFNDHVETNGFSS

CHD9

371

Q3L8U1
KHFHGTSLTFSMQDG

FHIT

71

P49789
GSMNVTLFHKASHPD

KLHL25

16

Q9H0H3
GHFAHPSFAASLKMG

DACT2

476

Q5SW24
FNASFSGHMTDPNFK

BRCA2

516

P51587
AFDQQPAMHHSFANI

CENPF

786

P49454
VHFKQHMQNQSDSGP

CUL4A

506

Q13619
AHLFMSFSNKFPHSS

DGKB

81

Q9Y6T7
HSFQPISFMHSSFQP

KRTAP25-1

71

Q3LHN0
SFSKDAQGPMGHFSQ

IGFN1

446

Q86VF2
DASFFGVHPKQAHTM

FASN

61

P49327
AGDFMHKNTSTDFPQ

DNA2

221

P51530
MGKSHVFRFNHPEQA

KIF1A

586

Q12756
EDHKETFTNMSHPGG

PRR14L

491

Q5THK1
MGSGTSTQHHFAFQN

PPEF2

1

O14830
TGLSMNTHFKAPAFH

MN1

26

Q10571
HTFMFSGIHPQDIKN

SYTL5

641

Q8TDW5
HAGDTPMINFDFHQF

SYNJ2

326

O15056
FFHHKAMQGTEVGQT

MIA3

691

Q5JRA6
FNNGNHEAVKSMFHT

SMYD1

216

Q8NB12
PAHAFNHTPKTMNGD

KIAA1217

266

Q5T5P2
NKTSPMSHSFANFHY

WDR47

336

O94967
QHPSEAMNAHTPQFF

USP19

976

O94966
SNHSGKVFNEHPFLM

ZNF846

116

Q147U1
FSKPQAFMDHTQSHG

ZFHX2

246

Q9C0A1
DDFRGHLFSHPQQSM

STOX1

576

Q6ZVD7
HFPQKFQLFNTSHMP

STOX1

896

Q6ZVD7
NIAHHGTFMEEFNSG

UBE4B

1006

O95155
FPNHSFKHEDPMGQQ

WT1

171

P19544
KAVSFHGVEPQMSHQ

TSKS

51

Q9UJT2
AKEHGHSTPQMAATF

ELAC1

286

Q9H777
GSSHFPHQKASLEHM

ZC3H12B

496

Q5HYM0
GFVHNHFSDSDAKMF

PLCH1

1441

Q4KWH8
EHSFQHPFLQAVGMF

SLC35F6

41

Q8N357
MASNHPAFSFHQKQV

ZCCHC14

1

Q8WYQ9
PDKANANHHSFQMYT

VAV2

516

P52735
INSSSFKSHMQTHPG

ZNF559

391

Q9BR84
QFVGHMNSEHTDFNK

ZHX3

91

Q9H4I2
FSFNSFHPDTRKPMH

THAP4

466

Q8WY91
MQHTHGFKAFHILPQ

TTLL5

141

Q6EMB2
PHLKLADFGFAQHMS

ULK3

151

Q6PHR2
MEAAGGFQVHFHPSN

KTN1-AS1

1

Q86SY8
PNLKMTSHHFEGAQI

MYO6

671

Q9UM54